Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Endotronix-Inc-trial

More Like This

PR Newswire associated0

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

PR Newswire associated0

ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM

PR Newswire associated0

Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure

PR Newswire associated0

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease

Carillon Mitral Contour System®

Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System®

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026